Grant Luo
About Grant Luo
Grant Luo serves as the Executive Director of Statistical Programming at Alpine Immune Sciences, Inc., bringing extensive experience from previous roles at Gilead Sciences, Corvus Pharmaceuticals, and other notable companies in the pharmaceutical sector.
Work at Alpine Immune Sciences
Grant Luo serves as the Executive Director of Statistical Programming at Alpine Immune Sciences, Inc. since 2021. In this role, he oversees the statistical programming functions and leads initiatives to enhance the company's programming capabilities. His experience in statistical programming and management contributes to the development of innovative therapies at the organization.
Previous Experience in Statistical Programming
Prior to his current role, Grant Luo held several significant positions in the field of statistical programming. He worked at Assembly Biosciences, Inc. as Senior Director of Statistical Programming from 2019 to 2021. Before that, he was the Director of Statistical Programming at Rigel Pharmaceuticals Inc. from 2017 to 2019 and at Corvus Pharmaceuticals from 2016 to 2017. His tenure at Gilead Sciences as Senior Manager of Statistical Programming lasted from 2013 to 2016.
Education and Expertise
Grant Luo earned a Master's degree in Mathematical Sciences with a concentration in Statistics from The University of Memphis from 2000 to 2001. He furthered his education at UC Berkeley Extension, where he studied Advanced Project Management from 2008 to 2009. His educational background supports his expertise in statistical programming across multiple therapeutic areas, including oncology.
Key Contributions and Projects
Throughout his career, Grant Luo has managed and contributed to significant projects in the pharmaceutical industry. At Genentech, he managed the programming team for the Avastin Glioblastoma indication ODAC and FDA sBLA submission. He also led the programming team for the TAF HBV submission at Gilead Sciences. His experience includes overseeing submissions for AFINITOR breast cancer indications to regulatory agencies at Novartis.
Career Progression in the Pharmaceutical Industry
Grant Luo's career in the pharmaceutical industry spans over two decades, with a focus on statistical programming. He began as a Senior Statistical Programmer at Genentech from 2006 to 2009, then progressed to Principal Statistical Programmer at Novartis from 2009 to 2013. His roles have consistently involved leadership and management of programming teams, demonstrating his growth and expertise in the field.